Neoeriocitrin (Synonyms: Eriodictyol 7-O-neohesperidoside) |
Katalog-Nr.GC40847 |
Neoeriocitrin, isoliert aus Drynaria Rhizome,zeigt AktivitÄt bei der Proliferation und osteogenen Differenzierung in MC3T3-E1.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 13241-32-2
Sample solution is provided at 25 µL, 10mM.
Neoeriocitrin is a flavonoid that has been found in C. paradisi and has antioxidative and osteogenic activities. It inhibits the production of 2,2-diphenyl-1-picrylhydrazyl radicals by 17.2% and the formation of superoxide radicals by 48.3% in cell-free assays, as well as decreases the rate of LDL oxidation ex vivo in isolated hamster plasma. Neoeriocitrin (2 µg/ml) increases proliferation of MC3T3-E1 osteoblast percursor cells and reverses the antiproliferative effect of the MEK1 inhibitor PD 98059 . It also increases the expression of the osteogenic differentiation markers Runx2, Type 1 collagen, and osteocalcin.
Average Rating: 5
(Based on Reviews and 4 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *